Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$128.91|
|52 Week High||US$98.94|
|52 Week Low||US$135.89|
|1 Month Change||0.34%|
|3 Month Change||3.05%|
|1 Year Change||25.18%|
|3 Year Change||29.99%|
|5 Year Change||48.62%|
|Change since IPO||6,197.90%|
Recent News & Updates
|MDT||US Medical Equipment||US Market|
Return vs Industry: MDT underperformed the US Medical Equipment industry which returned 34.7% over the past year.
Return vs Market: MDT underperformed the US Market which returned 31.5% over the past year.
Stable Share Price: MDT is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: MDT's weekly volatility (2%) has been stable over the past year.
About the Company
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.
Medtronic Fundamentals Summary
|MDT fundamental statistics|
Is MDT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MDT income statement (TTM)|
|Cost of Revenue||US$10.44b|
Last Reported Earnings
Jul 30, 2021
Next Earnings Date
Nov 23, 2021
|Earnings per share (EPS)||2.89|
|Net Profit Margin||12.29%|
How did MDT perform over the long term?See historical performance and comparison
2.0%Current Dividend Yield
Does MDT pay a reliable dividends?See MDT dividend history and benchmarks
|Medtronic dividend dates|
|Ex Dividend Date||Sep 23 2021|
|Dividend Pay Date||Oct 15 2021|
|Days until Ex dividend||1 day|
|Days until Dividend pay date||21 days|
Does MDT pay a reliable dividends?See MDT dividend history and benchmarks
Is Medtronic undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MDT ($128.91) is trading above our estimate of fair value ($111.87)
Significantly Below Fair Value: MDT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MDT is good value based on its PE Ratio (44.7x) compared to the US Medical Equipment industry average (50.5x).
PE vs Market: MDT is poor value based on its PE Ratio (44.7x) compared to the US market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: MDT is poor value based on its PEG Ratio (5x)
Price to Book Ratio
PB vs Industry: MDT is good value based on its PB Ratio (3.4x) compared to the US Medical Equipment industry average (4.7x).
How is Medtronic forecast to perform in the next 1 to 3 years based on estimates from 26 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDT's forecast earnings growth (8.9% per year) is above the savings rate (2%).
Earnings vs Market: MDT's earnings (8.9% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: MDT's earnings are forecast to grow, but not significantly.
Revenue vs Market: MDT's revenue (5.1% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: MDT's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDT's Return on Equity is forecast to be low in 3 years time (16.3%).
How has Medtronic performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDT has a large one-off loss of $1.5B impacting its July 30 2021 financial results.
Growing Profit Margin: MDT's current net profit margins (12.3%) are lower than last year (15.8%).
Past Earnings Growth Analysis
Earnings Trend: MDT's earnings have grown by 1% per year over the past 5 years.
Accelerating Growth: MDT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MDT had negative earnings growth (-12.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (40.5%).
Return on Equity
High ROE: MDT's Return on Equity (7.6%) is considered low.
How is Medtronic's financial position?
Financial Position Analysis
Short Term Liabilities: MDT's short term assets ($22.4B) exceed its short term liabilities ($7.8B).
Long Term Liabilities: MDT's short term assets ($22.4B) do not cover its long term liabilities ($32.4B).
Debt to Equity History and Analysis
Debt Level: MDT's debt to equity ratio (50.1%) is considered high.
Reducing Debt: MDT's debt to equity ratio has reduced from 62.9% to 50.1% over the past 5 years.
Debt Coverage: MDT's debt is well covered by operating cash flow (28%).
Interest Coverage: MDT's interest payments on its debt are well covered by EBIT (9.1x coverage).
What is Medtronic current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MDT's dividend (1.95%) is higher than the bottom 25% of dividend payers in the US market (1.37%).
High Dividend: MDT's dividend (1.95%) is low compared to the top 25% of dividend payers in the US market (3.67%).
Stability and Growth of Payments
Stable Dividend: MDT's dividends per share have been stable in the past 10 years.
Growing Dividend: MDT's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (82.1%), MDT's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MDT's dividends in 3 years are forecast to be well covered by earnings (38.8% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Geoff Martha (51 yo)
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Chairman at Medtron...
CEO Compensation Analysis
Compensation vs Market: Geoff's total compensation ($USD16.47M) is above average for companies of similar size in the US market ($USD11.42M).
Compensation vs Earnings: Geoff's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: MDT's management team is seasoned and experienced (6.3 years average tenure).
Experienced Board: MDT's board of directors are considered experienced (7.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medtronic plc's employee growth, exchange listings and data sources
- Name: Medtronic plc
- Ticker: MDT
- Exchange: NYSE
- Founded: 1949
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$173.488b
- Shares outstanding: 1.35b
- Website: https://www.medtronic.com
Number of Employees
- Medtronic plc
- 20 On Hatch
- Lower Hatch Street
- Co. Dublin
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 22:31|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.